We demonstrate herein that a blockade of TGF-β actions releases stromal cells from their differentiation arrest by MM, and that terminally differentiated OBs inhibit MM cell growth and survival and potentiate responsiveness to anti-MM agents. The gene discussed is TGFB1; the disease is Miyoshi myopathy.